Oxford Immunotec to Present at the Cowen and Company 36th Annual Health Care Conference
OXFORD, United Kingdom and MARLBOROUGH, Mass., 2016-02-23 16:34 CET (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, and Richard Altieri, Chief Financial Officer, will present at the Cowen and Company 36thAnnual Health Care Conference on Tuesday, March 8, 2016, at 9:20 a.m. EST at the Boston Marriott Copley Place in Boston, MA.
A live webcast of the presentation will be available online from the investor relations page of the Company's corporate website atwww.oxfordimmunotec.com. A webcast replay will be available approximately 24 hours after the live presentation and will be archived on the website for approximately 60 days.
Oxford Immunotec Global PLC is a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions. The Company's first product is the T-SPOT®.TBtest, which is used to test for tuberculosis infection. The T-SPOT.TBtest has been approved for sale in over 50 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China. The T-SPOT.CMVtest and the T-SPOT.PRTtest are the Company's second and third products and part of a series of products intended for the transplantation market. In addition to these three products, the Company has an additional six active development programs, each of which leverages our T cell, B cell and innate immune measuring technology. The Company is headquartered near Oxford, U.K. and in Marlborough, Mass. Additional information can be found atwww.oxfordimmunotec.com.
T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.
For Media Inquiries:
Tel: +44 1235 442796
For Investor Inquiries:
Chief Financial Officer
Tel: +1 (508) 573-9953
Tel: +1 (443) 213-0500
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Inspiration Mining Corporation20.2.2018 21:37 | pressemeddelelse
Inspiration Mining to File a Complaint with OSC Against Stockwatch
Aurora Solar Technologies Inc.20.2.2018 21:09 | pressemeddelelse
Aurora Releases Third Quarter Results
Bermuda Business Development Agency (BDA)20.2.2018 16:38 | pressemeddelelse
Bermuda Principles event merges science and business
Elite Capital & Co. Limited20.2.2018 15:43 | pressemeddelelse
Elite Capital & Co. awarded Infrastructure Project Finance Provider 2018 by New European Economy
Corel20.2.2018 15:28 | pressemeddelelse
New MindManager 11 for Mac: Visually Capture, Organize, and Share Information to Drive Project and Business Success
Cisco20.2.2018 14:02 | pressemeddelelse
Cisco Leadership In Automation Continues With New Network Automation Portfolio for Service Providers
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum